Sign up Australia
Proactive Investors - Run By Investors For Investors

Ironbark Zinc attracts $0.35 target from Perth broker

Ironbark is focussed on the Citronen Fjord Zinc project in Greenland.
Ironbark Zinc attracts $0.35 target from Perth broker
Ironbark shares have added 10% to $0.078 intra-day

Ironbark Zinc Ltd (ASX:IBG) is currently trading in the $0.07 range, with Perth broker Patersons outlining a strong upside potential with a $0.35 target price.

Patersons considers the stock to be highly leveraged to the Citronen Fjord Zinc project which it says is likely to be funded in the near-term.

Adding interest, Ironbark has an undrawn US$50 million funding facility provided by Glencore to expand its project base through acquisition.

The following is an extract from the report.

Investment Highlights

We are initiating coverage of Ironbark Zinc Limited (IBG) with a Speculative Buy rating and $0.35/sh price target.

IBG is focussed on developing its fully permitted Citronen Fjord Zinc project (100%) (Citronen) located in northern Greenland.

The project is a globally significant zinc project with a contemplated 14-year mine life and peak production rate of c.200,000tpa of zinc metal.

In addition, the deposit has outstanding exploration upside.

Based on our price forecasts, we estimate the project generates >US$150mpa in freecash generation with a payback period of c.2.5 years.

We believe that the current supportive zinc pricing environment should allow the project to be financed and move towards construction potentially in 2018.

IBG has a supportive shareholder base with Nyrstar and Glencore on the register.

In addition, IBG has the support of China Non-Ferrous (NFC) who are looking to potentially fund the project.

Significant Zinc Project with Strong Upside

We see the Citronen Project as having the potential to significantly exceed the contemplated 14-year mine life.

Citronen is a SEDEX style deposit and these tend to be very large whilst maintaining excellent grades.

IBG has published an exploration target of 302-347Mt at 4.4-5% Zn over the 11km of strike of known mineralisation which suggests a potential mine life of over 100 years is possible.

This significantly exceeds the last published Mineral Resource of 70.8Mt at 5.7% Zn+Pb.

Funding the Key for Development

We believe the current supportive zinc pricing environment will likely allow Citronen to be funded.

IBG recently signed a MoU with China Non-Ferrous for an engineering procurement and construction (EPC) lump sum, fixed price construction and commissioning contract with associated 70% debt and 20% direct project investment.

In addition, IBG is examining alternative non-Chinese proposals for project funding.

Supportive Shareholders

IBG has a supportive shareholder base with Nyrstar and Glencore owning 19% and 9% of the stock respectively.

Treatment charges especially out of China are rapidly reducing as there is increased demand for good quality zinc concentrates (such as Citronen) to blend with lower quality ores.


We have determined a valuation of $0.35/sh.

Our valuation is based on the recent updated feasibility assuming the project is funded 70% debt and 30% equity via a highly dilutive capital raising.

View full IBG profile View Profile

Ironbark Zinc Ltd Timeline

Related Articles

March 07 2018
Production at Thalanga is forecast to grow more than 50% between 2018 and 2019.
July 19 2017
Medgold has earmarked drilling to start at the Tlamino project in Serbia in August
May 15 2017
Kazakhstan's decision to curtail uranium output by 10% from its mines gave a shot in the arm to the sector

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use